Vitamin D supplements in Prediabetes patients reduce type 2 diabetes risk, says study
Vitamin D
supplementation in patients with prediabetes significantly reduces the
risk of type 2 diabetes (T2D), suggests a recent study published in the
Journal of Clinical Endocrinology & Metabolism.
The effect of vitamin D supplementation on T2D risk remains
controversial. Most randomized controlled trials (RCTs) have been small
or have reported low doses of vitamin D.
Mahmoud Barbarawi, Department of Internal Medicine, Hurley Medical
Center/Michigan State University, Flint, MI, USA, and colleagues
conducted a meta-analysis of RCTs testing vitamin D supplementation in
the prevention of T2D.
The researchers
performed a database search of PubMed/MEDLINE, EMBASE, and the Cochrane
Library from inception through September 15, 2019. RCTs that reported
the effect of vitamin D supplementation for at least 1 year on T2D
prevention, were included.
Two independent reviewers extracted the data. The risk ratios (RRs) and
95% confidence intervals (CIs) were reported. The primary outcome of the
meta-analysis was the incidence of T2D.
"In patients with prediabetes, vitamin D supplementation at moderate to high doses (≥1000 IU/day), significantly reduced the incidence risk of T2DM, compared with placebo," concluded the authors.